These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 459511)

  • 21. Oligomeric structure of cholera toxin: characteristics of the H and L subunits.
    Holmgren J; Lonnroth I
    J Gen Microbiol; 1975 Jan; 86(1):49-65. PubMed ID: 803547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interaction of cholera toxin subunit A with cultured adrenal cells.
    Knoop FC
    Can J Microbiol; 1978 Aug; 24(8):915-21. PubMed ID: 688100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms.
    Magnani JL; Smith DF; Ginsburg V
    Anal Biochem; 1980 Dec; 109(2):399-402. PubMed ID: 7224165
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro radiolabeling procedure which labels the proteins of Newcastle disease virions with carbon-14.
    McMillen J; Consigli RA
    Infect Immun; 1975 Dec; 12(6):1411-4. PubMed ID: 1205619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a phosphorylated non-structural form of the P protein of Newcastle disease virus and analysis of P multimers.
    Hightower LE; Collins PL; Smith GW
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1631-6. PubMed ID: 6470685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholera Toxin as a Probe for Membrane Biology.
    Kenworthy AK; Schmieder SS; Raghunathan K; Tiwari A; Wang T; Kelly CV; Lencer WI
    Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunoassay for the antigenic determinants of cholera toxin and its components.
    Hejtmancik KE; Peterson JW; Markel DE; Kurosky A
    Infect Immun; 1977 Sep; 17(3):621-8. PubMed ID: 71268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hydrophobicities of cholera toxin, tetanus toxin and their components.
    Ward WH; Britton P; van Heyningen S
    Biochem J; 1981 Nov; 199(2):457-60. PubMed ID: 7340813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of tritium-labeled cholera toxin.
    Banwell JG; Hanke DW; Diedrich D
    Infect Immun; 1978 Aug; 21(2):613-8. PubMed ID: 689738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-Depth Characterization of a Re-Engineered Cholera Toxin Manufacturing Process Using Growth-Decoupled Production in
    Danielewicz N; Dai W; Rosato F; Webb ME; Striedner G; Römer W; Turnbull WB; Mairhofer J
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photoreactive labeling of M13 coat protein in model membranes by use of a glycolipid probe.
    Hu VW; Wisnieski BJ
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5460-4. PubMed ID: 293655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in conformation and charge paralleling proteolytic activation of Newcastle disease virus glycoproteins.
    Kohama T; Garten W; Klenk HD
    Virology; 1981 Jun; 111(2):364-76. PubMed ID: 7245609
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipid-protein interactions during ricin toxin insertion into membranes. Evidence for A and B chain penetration.
    Ishida B; Cawley DB; Reue K; Wisnieski BJ
    J Biol Chem; 1983 May; 258(9):5933-7. PubMed ID: 6853559
    [No Abstract]   [Full Text] [Related]  

  • 34. Difference in resistance of subunits A and B of Vibrio cholerae toxin (choleragen) to treatment with pronase.
    Neri P; Antoni G; Tarli P
    Experientia; 1978 Oct; 34(10):1293-4. PubMed ID: 738397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Origin of the enzymatically active A1 fragment of cholera toxin.
    Gill DM; Rappaport RS
    J Infect Dis; 1979 Jun; 139(6):674-80. PubMed ID: 448194
    [No Abstract]   [Full Text] [Related]  

  • 36. Structural studies on the polypeptide substrates of cholera toxin.
    Ward WH; van Heyningen S
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1181-7. PubMed ID: 7181889
    [No Abstract]   [Full Text] [Related]  

  • 37. The structural proteins of Newcastle disease virus. II. Proteolytic digestion of the M-protein.
    Iinuma M
    Microbiol Immunol; 1980; 24(2):185-6. PubMed ID: 7382858
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta sheet of alpha helix transition in the binding subunit of cholera toxin.
    Robinson RM; Hamed MM; Mattice WL
    Biochem Biophys Res Commun; 1982 Mar; 105(2):398-403. PubMed ID: 7092863
    [No Abstract]   [Full Text] [Related]  

  • 39. The amino terminal sequence of cholera toxin subunits.
    Jacobs JW; Niall HD; Sharp GW
    Biochem Biophys Res Commun; 1974 Nov; 61(2):391-5. PubMed ID: 4455227
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiation studies on the infective property of Newcastle disease virus.
    WILSON D; POLLARD E
    Radiat Res; 1958 Feb; 8(2):131-41. PubMed ID: 13506042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.